Attending #BidenCancerSummit for Project ECHO
First – apologies to readers – I have not posted in a good while, for life reasons. I am doing very well and had the chance of a lifetime earlier this year to join the […]
DCIS is the precursor lesion for most #malebreastcancer similar to female
Male breast cancer precursor lesions: analysis of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program. Doebar SC, Slaets L, Cardoso F, Giordano SH, Bartlett JM, Tryfonidis K, Dijkstra NH, Schröder CP, van Asperen CJ, Linderholm […]
next gen sequencing finds BRCA1/BRCA2 mutations in “negative” #malebreastcancer patients
Retesting BRCA1/BRCA2 mutation negative male breast cancer patients using next generation sequencing technologies Piera Rizzolo Valentina Silvestri and Laura Ottini Breast Cancer Res Treat DOI 10.1007/s10549-017-4108-9 Background BRCA1 and BRCA2 are well known, high penetrance […]
Please consider supporting #malebreastcancer research
Welcome to October – the month we think more about breast cancer than usual. This is a quick post and appeal to my regular readers and a welcome to first time visitors. I have written […]
Genome methylation patterns in male breast cancer – Identification of an epitype with hypermethylation of polycomb target genes
Genome methylation patterns in male breast cancer – Identification of an epitype with hypermethylation of polycomb target genes Johansson I, Lauss M, Holm K, Staaf J, Nilsson C, Fjällskog ML, Ringnér M, Hedenfalk I Mol […]
Tamoxifen in men: a review of adverse events shows its mostly well tolerated but some issues do arise
Tamoxifen in men: a review of adverse events Wibowo E, Pollock PA, Hollis N, Wassersug RJ Andrology. 2016 Sep;4(5):776-88. doi: 10.1111/andr.12197. Epub 2016 May 6 Background Most male breast cancer is hormone dependent, via estrogen […]
The Genomic Landscape of Male Breast Cancers by Piscuoglio et al
The Genomic Landscape of Male Breast Cancers Piscuoglio S, Ng CK, Murray MP, Guerini-Rocco E, Martelotto LG, Geyer FC, Bidard FC, Berman S, Fusco N, Sakr RA, Eberle C, De Mattos-Arruda L, Macedo GS, Akram […]
Thank you to The ASCO Post: Is #MaleBreastCancer Overlooked in Clinical Trials? –
Story: Is Male Breast Cancer Overlooked in Clinical Trials? – The ASCO Post I want to thank the ASCO Post for running this story – it is much appreciated!
Thank you #ASBrS for the chance to speak about clinical trials for #malebreastcancer
Yesterday I was honored to speak at a session on Clinical Trials at the annual meeting of the American Society of Breast Surgeons in Dallas. Dr. Deanna Attai, the President of ASBrS and a breast […]
Risk of Second Non-Breast Primary Cancer in Male and Female Breast Cancer Patients: A Population-Based Cohort Study. – PubMed – NCBI
Risk of Second Non-Breast Primary Cancer in Male and Female Breast Cancer Patients: A Population-Based Cohort Study Hung MH, Liu CJ, Teng CJ, Hu YW, Yeh CM, Chen SC, Chien SH, Hung YP, Shen CC, […]
